Executive Q&A: How to make the annual benefits reverification process as smooth as possible for patients and key stakeholders.

Executive Q&A: best practices for a patient support program launch.

In this digital age, how can pharmaceutical manufacturers leverage innovative tools to prove their product's value proposition and overcome market access challenges?

Two experts in health economics and patient support team up to offer insight on how manufacturers can prepare for the impact of copay accumulators.

Executive Q&A: How shifting coverage for some drugs from Medicare Part B to Part D could impact access and affordability for patients.

What are the pitfalls of historic approaches to adherence? Learn how leading solutions combine both measurement and engagement for real results.

Open enrollment for Health Insurance Marketplace plans is here. Do PAP patients know their coverage options?

How leading patient support providers combine measurement with engagement to improve adherence.

The evolving needs of the patient and historic approaches to non-adherence.

Patients face a growing number of barriers that can impede medication access and adherence. How can manufacturers help address these hurdles?

How is manufacturer thinking around channel strategy changing for oral oncolytics?

How can manufacturers approach reimbursement and patient support for cell and gene therapies and other medical innovations?

What does the future of benefit verification look like for manufacturer patient support programs?

Learn what it takes to design an effective commercialization strategy and execute an integrated solution when the patient is in the supply chain.